SeaSpine Holdings Corporation Provides Revenue Guidance for the Fourth Quarter of 2020

SeaSpine Holdings Corporation is a global medical technology company. The Company is focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. It offers a portfolio of orthobiologics and spinal implant solutions, as well as a surgical navigation system, to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar, thoracic, and cervical spine. Its orthobiologics products consist of a range of advanced and traditional bone graft substitutes designed to improve bone fusion rates following a range of orthopedic surgeries, including spine, hip, and extremities procedures. The Company's spinal implants and enabling technologies portfolio consists of a line of products and image-guided surgical solutions to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures.